Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations

Journal of the American Geriatrics Society

Volumn 46, Issue 7, 1998, Pages 822-828

  Kiel, Douglas P ^a,b,f   Puhl, Jacqueline ^b   Rosen, Clifford J ^d   Berg, Katherine ^c   Murphy, John B ^e   MacLean, David B ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d ST JOSEPH HOSPITAL   (United States)

^e MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^f RESEARCH AND TRAINING INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGED; AGING; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; FUNCTIONAL ASSESSMENT; GROWTH HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

EID: 0031868927     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb02714.x     Document Type: Article

References (32)

1. Rudman D, Kutner MH, Rogers CM et al. Impaired growth hormone secretion in the adult population: Relation to age and adiposity. J Clin Invest 1981;67:1361-1369.
2. Finklestein JW, Boyar RM, Roffwarg HP et al. Age-related change in the twenty-four hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 1972;35:665-670.
3. Clemmons DR, Van Wyck JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984;67:113-143.
4. Rudman D, Feller AG, Nagraj HS et al. Growth hormone, body composition, and aging. J Am Geriatr Soc 1985;33:800-807.
5. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14:20-37.
6. Cuneo RC, Salamon F, Wiles CM et al. Growth hormone treatment in growth hormone-deficient adults: I. Effects on muscle mass and strength. J Appl Physiol 1991;70:688-694.
7. Degerblad M, Almkvist O, Grunditz R et al. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol 1990;123:185-193.
8. Rudman D, Feller AG, Nagraj HS et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.
9. Papadakis MA, Grady D, Black D et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124:708-716.
10. Bondy CA, moderator. Clinical uses of insulin-like growth factor I. Ann Intern Med 1994;120:593-601.
11. Johanson AJ, Blizzard RM. Low somatomedin-C levels in older men rise in response to growth hormone administration. John Hopkins Med J 1981;149:115-117.
12. Poehlman ET, Copeland KC. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab 1990;71:1468-1473.
13. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G et al. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 1994;41:351-357.
14. Papadakis MA, Grady D, Tierney MJ et al. Insulin-like growth factor 1 and functional status in healthy older men. J Am Geriatr Soc 1995;43:1350-1355.
15. Harris TB, Kiel DP, Roubenoff R et al. Association of insulin-like growth factor I with body composition, weight history and past health behaviors in the very old: The Framingham Heart Study. J Am Geriatr Soc 1997;45:133-139.
16. Boonen S, Lesaffre E, Aerssens J et al. Deficiency of the growth hormone-insulin-like growth factor I axis potentially involved in age-related alterations in body composition. Gerontology 1996;42:330-338.
17. Jorgensen JO, Christiansen JS, Hagen C et al. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: Increase in exercise capacity and normalization of body composition. Clin Endocrinol 1996;45:681-688.
18. Reuben DB, Siu AL. An objective measure of physical function of elderly outpatients: The physical performance test. J Am Geriatr Soc 1990;38:1105-1112.
19. Breier BH, Gallaher BW, Gluckman PD. Radioimmunoassay for insulin-like growth factor-1: Solutions to some potential problems and pitfalls. J Endocrinol 1991;128:347-357.
20. Grogean T, Vereault D, Millard PS et al. A comparative analysis of methods to measure insulin-like growth factor-I in human serum. Endocrinol Metab 1997;4:109-114.
21. Nagi SZ. An epidemiology of disability among adults in the United States. Milbank Q 1976;54:439-468.
22. Washburn RA, Smith DW, Jette AM, Janney CA. The physical activity scale for the elderly (PASE): Development and evaluation. J Clin Epidemiol 1993;46:153-162.
23. McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-Item Short-Form Health Survey(SF-36).III: Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 1994;32:40-66.
24. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Status Survey Manual. Boston: The Health Institute, New England Medical Center, 1993.
25. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
26. SPSS Inc. SPSS Reference Guide, Release 4. Chicago: SPSS Inc., 1990, pp 585-604.
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences, Rev Ed. New York: Academic Press, 1977.
28. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. Diagnosis of growth-hormone deficiency in adults. Lancet 1994;343:1064-1068.
29. O'Connor KG, Harman SM, Bellantoni M et al. Relationships among GH, IGF-I, metabolic and body composition variables in healthy old persons. Gerontologist (Abstract) 1994;34:152.
30. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101.
31. Verhaeghe J, Gouillon R. Effects of diabetes and insulin on bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego: Academic Press, 1996, pp 549-561.
32. Valcavi R, Dieguez C, Preece M et al. Effect of thyroxine replacement therapy on plasma IGF-I levels and growth hormone responses to GH releasing factor in hypothyroid patients. Clin Endocrinol 1987;27:85-90.